PolyPid Net Worth

PolyPid Net Worth Breakdown

  PYPD
The net worth of PolyPid is the difference between its total assets and liabilities. PolyPid's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of PolyPid's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. PolyPid's net worth can be used as a measure of its financial health and stability which can help investors to decide if PolyPid is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in PolyPid stock.

PolyPid Net Worth Analysis

PolyPid's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including PolyPid's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of PolyPid's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform PolyPid's net worth analysis. One common approach is to calculate PolyPid's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares PolyPid's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing PolyPid's net worth. This approach calculates the present value of PolyPid's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of PolyPid's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate PolyPid's net worth. This involves comparing PolyPid's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into PolyPid's net worth relative to its peers.
To determine if PolyPid is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding PolyPid's net worth research are outlined below:
PolyPid is way too risky over 90 days horizon
PolyPid appears to be risky and price may revert if volatility continues
PolyPid has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (29.02 M) with profit before overhead, payroll, taxes, and interest of 0.
PolyPid currently holds about 23.78 M in cash with (21.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22.
Roughly 25.0% of the company outstanding shares are owned by corporate insiders
PolyPid uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in PolyPid. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to PolyPid's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
14th of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Follow PolyPid's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 30.32 M.
PolyPid time-series forecasting models is one of many PolyPid's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PolyPid's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

PolyPid Earnings per Share Projection vs Actual

PolyPid Corporate Management

Ori WarshavskyChief USProfile
Dikla AkselbradChief OfficerProfile
Malka ReichartScientific DirectorProfile
Rivi LevariVice ResourceProfile
Orna BlumLegal CounselProfile
JeanMarc PharmDChief OfficerProfile
Tal VilnaiGeneral SecretaryProfile
When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.